Form 4 holding
Chief Executive Officer, Director
MIMEDX GROUP, INC.
- Security class
- Common Stock
- Shares / value
- 1,711,324
- Estimated value
- $12,248,459
- Report date
- 09 Jun 2022
- Price
- $7.16
- Ownership
- Direct
Timothy R. Wright
Insider Reports History
- Reporting-owner location
- Raleigh, NC
- Latest reporting-owner signature
-
/s/ Timothy R. Wright
Source: Latest parsed Forms 3/4/5 signature
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for Timothy R. Wright
Form 4 holding
Director
Protagenic Therapeutics, Inc.\new
- Security class
- PTIX Common stock Options
- Shares / value
- 21,250
- Estimated value
- $36,975
- Report date
- 25 Mar 2024
- Price
- $1.74
- Ownership
- Direct
- Underlying class
- PTIX Common Stock, Par Value $0.0001
- Underlying amount
Insider Reports Filed by Timothy R. Wright
4
PTIX
Protagenic Therapeutics, Inc.\new
- Report period
- 25 Mar 2024
- Transactions
- 1
- Transaction value
- +$36,975
- Accepted by SEC
- 01 Apr 2024, 21:41
- Role
- Director
- Next action
- Open filing details
4
MDXG
MIMEDX GROUP, INC.
- Report period
- 09 Jun 2022
- Transactions
- 1
- Transaction value
- -$420,000
- Accepted by SEC
- 13 Jun 2022, 18:45
- Role
- Chief Executive Officer, Director
- Next action
- Open filing details
4
MDXG
MIMEDX GROUP, INC.
- Report period
- 08 Apr 2022
- Transactions
- 1
- Transaction value
- +$2,784,377
- Accepted by SEC
- 12 Apr 2022, 17:30
- Role
- Chief Executive Officer, Director
- Next action
- Open filing details
4
MDXG
MIMEDX GROUP, INC.
- Report period
- 08 Mar 2022
- Transactions
- 1
- Transaction value
- -$221,624
- Accepted by SEC
- 10 Mar 2022, 15:31
- Role
- Chief Executive Officer, Director
- Next action
- Open filing details
4
MDXG
MIMEDX GROUP, INC.
- Report period
- 23 Feb 2022
- Transactions
- 1
- Transaction value
- -$263,075
- Accepted by SEC
- 25 Feb 2022, 16:11
- Role
- Chief Executive Officer, Director
- Next action
- Open filing details
4
MDXG
MIMEDX GROUP, INC.
- Report period
- 08 Jun 2021
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 09 Jun 2021, 16:09
- Role
- Chief Executive Officer, Director
- Next action
- Open filing details